Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
C-RAD Receives Order Worth Approximately SEK 8 Million From Northeastern U.S. Medical Center

C-RAD Receives Order Worth Approximately SEK 8 Million From Northeastern U.S. Medical Center

BitgetBitget2026/10/28 07:06
  • C-RAD received an order worth approximately SEK 8 million from a leading academic medical center in the northeastern United States.
  • The order includes multiple Catalyst⁺ HD systems to support radiation therapy across different linear accelerator platforms.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C-RAD AB published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US LNG Exports Reach Record High as Europe and Asia Hope for Winter Price Relief

U.S. liquefied natural gas exports have reached record highs, potentially easing market pressures caused by war-related disruptions.

智通财经•2026/11/16 07:01
US LNG Exports Reach Record High as Europe and Asia Hope for Winter Price Relief

Light-asset cross-border logistics service provider CloudDepots sets IPO pricing at $5 to $6, aiming to raise up to $17 million

Logistics service provider CloudDepots Holdings has filed for a $17 million initial public offering.

智通财经•2026/11/16 06:58
Light-asset cross-border logistics service provider CloudDepots sets IPO pricing at $5 to $6, aiming to raise up to $17 million

Inflammatory disease biotechnology company Rezera (RZRA.US) delays $200 million IPO in the US

Biotechnology company Rezera announced last Thursday that it will postpone its listing.

智通财经•2026/11/16 06:58
Inflammatory disease biotechnology company Rezera (RZRA.US) delays $200 million IPO in the US